NewsBenzinga美国食品药品监督管理局批准百时美施贵宝的 Camzyos 作为首个用于体重至少30公斤、患有梗阻性肥厚型心肌病的儿童治疗药物 美国食品药品监督管理局批准百时美施贵宝的 Camzyos 作为首个用于体重至少30公斤、患有梗阻性肥厚型心肌病的儿童治疗药物 Benzinga 2026.09.30 18:48 (GMT+0) Open on Benzinga Other news Vitalik: Ethereum should move heavy cryptographic computation to clients, with on-chain only verifying proofs and results 'This Is What I Will Be Doing’: Elon Musk Says He’ll Give Shares To The Public After Anthropic Announces 5% Fund BlackRock: Tokenized Funds Are Accelerating Their Integration into Wall Street's Underlying Financial Plumbing SentinelOne: Clear Market Share Gains As AI Paranoia Drives Deals (NYSE:S) The Winners Inside SCHD - October 2026 Trader liquidates PONS and AI tokens, losing $645,000 in 10 hours
Vitalik: Ethereum should move heavy cryptographic computation to clients, with on-chain only verifying proofs and results
'This Is What I Will Be Doing’: Elon Musk Says He’ll Give Shares To The Public After Anthropic Announces 5% Fund
BlackRock: Tokenized Funds Are Accelerating Their Integration into Wall Street's Underlying Financial Plumbing
